TürkiyeResearch and clinical trials
40 infants with infantile spasms in Ankara: oral cortisone and ACTH gave similar results
Gazi University studied 40 infants with infantile spasms.
Neuromuscular diseases
A type of epilepsy that begins in infancy. The baby has brief contractions that come in clusters. Development may stop or go backward; early treatment is important.
Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source
This page is translated from the Turkish original.
This disease is followed through the “Neuromuscular diseases” group.
In West syndrome, the baby has brief contractions called infantile spasms. These usually begin between 4 and 8 months of age. The EEG shows chaotic, irregular brain waves. In many babies, development slows down or goes backward. A cause is found in most children; the most common cause is tuberous sclerosis.
Spasms can easily be mistaken for colic or normal movements.
An EEG is recorded during sleep for the diagnosis. An MRI is done to see the structure of the brain. Blood, urine and genetic tests may be requested to find the cause. It is important not to delay diagnosis and treatment.
The aim of treatment is to stop the spasms quickly. Hormone or cortisone treatment and an epilepsy medicine are the first options. The medicines stop the spasms in about 7 in 10 children. The ketogenic diet and other epilepsy medicines may also be tried. If there is a structural problem in the brain, surgery may help. Early treatment helps development to be less affected. The doctor who follows the disease decides which treatment is suitable.
Inheritance depends on the underlying cause. If the cause is tuberous sclerosis, the chance of passing it on is 1 in 2 in each pregnancy. Some gene changes are passed on through the X chromosome. These mostly affect boys. Causes such as lack of oxygen during birth or infection are not inherited. Genetic counselling helps the family understand its risk.
Source: NORD: West Syndrome · Young Epilepsy: Infantile spasms (West syndrome)
These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.
Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.
We could not find a patient association specific to this disease.
For all rare diseases: Nadir Hastalıklar Federasyonu
Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.
TürkiyeResearch and clinical trials
Gazi University studied 40 infants with infantile spasms.
TürkiyeResearch and clinical trials
In Istanbul, 24 babies diagnosed with infantile spasms were monitored during low-dose ACTH treatment.
A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.
Questions you can ask your doctor
ClinicalTrials.gov lists 3 active interventional studies for this disease. 3 are recruiting now; none has a site in Türkiye. Last checked: October 7, 2026.
Selected records (studies with a site in Türkiye first):
Middle stage: the effect is being tested in a small group · Phase 2 · investigational (experimental)RecruitingNCT04289467
Middle stage: the effect is being tested in a small group · Phase 2 · investigational (experimental)RecruitingNCT06819670
Non-drug study (device, procedure, care, etc.)RecruitingNCT04302116
See all studies on ClinicalTrials.gov · Joining clinical trials
InternationalResearch and clinical trials
The HIMALAYA study, published in The Lancet Neurology, examined an experimental drug in patients with ALS (amyotrophic lateral sclerosis).
TürkiyeResearch and clinical trials
A multicenter study in Istanbul compared patients with Guillain-Barré syndrome.
USANew treatments and approvals
The US Food and Drug Administration (FDA) approved levacetylleucine for balance and walking problems in ataxia-telangiectasia (A-T).
These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.
Orphanet code: ORPHA:3451 · ICD-11 8A62.0
Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.
This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.